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ABSTRACT
Multi-scale Modeling of Microbial Defection in the Presence of Antibiotics
by
Darshan Dilip Nahar, Master of Science
Utah State University, 2014

Major Professor: Dr. Nicholas Flann
Department: Computer Science
Iterative competition between organisms for limited resources gives rise to different social strategies including cooperation. One specific problem in the cooperating but competing species is that the cost associated in exhibiting cooperative traits provokes “cheating”.
Cheaters acquire relatively higher fitness by reaping the benefits of cooperation without contributing towards community beneficial goods. While the relatively fit cheaters can drive
the contributors to extinction, the contributors exhibit different strategies to gain preferential benefits of cooperation. The facultative benefit of cooperation to cheaters drives the
population to an equilibrium frequency of cooperators and cheaters. Here we develop a
multi-scale modeling approach to simulate the dynamics of such cooperation within mixed
population of contributors and cheaters. We recursively use genome-scale metabolic models
to estimate the fitness of the organism based on the current ecological state. In addition,
a series of ordinary differential equations estimate the dynamics of the population and ecological conditions. We use our approach to investigate alternative strategies whereby the
cooperating strain may improve its fitness and find that regulation of gene expression is
superior to modulation of enzyme activity in our system.
(41 pages)
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PUBLIC ABSTRACT
Multi-scale Modeling of Microbial Defection in the Presence of Antibiotics
by
Darshan Dilip Nahar
Limited environmental resources push life into competition. In terms of microbes, we
assume that the only goal is to grow and competition means to grow faster than the peers.
Organisms tend to adapt to their environmental conditions and improve their efficiency in
using the common resources to grow faster. While different organisms compete they engage
into various social behaviors like cooperation to work together towards a common goal, e.g.,
production of public goods that benefits the entire population. Hence a part of the resources
at hand is dedicated to participate in cooperative activities if the cost-to-benefit ratio is
less than one. Evolutionary pressures to outcompete encourage the organisms to “cheat”
by deploying all its resources for self-growth without exhibiting cooperative traits and yet
take the benefits of others’ altruistic actions. Thus cheaters achieve the cost-to-benefit
ratio of zero but the rise of cheaters cuts down the ability of the population to produce
public goods. To protect itself during the scarcity of public goods, the contributors exhibit
different strategies to limit the cheater’s access to the public goods. Thus, the ability
to cheat is conditional to excess production of public goods. This drives the population
to an equilibrium frequency of cheaters and contributors. Here we develop a multi-scale
mathematical model to study the dynamics of intercellular cooperation within microbes.
Our results show that, at equilibrium, the cheaters procure relatively reduced benefit from
the public goods, thus making their growth rates identical to the contributors.
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CHAPTER 1
INTRODUCTION
Life exists in a resource-limited world filled with a variety of stresses. Evolution via
natural selection promotes the development of species adapted to their environments. In
addition to physical factors, the environment is often comprised of other organisms. While
direct competition amongst organisms for limited resources plays a crucial part in evolution,
other social strategies including cooperation, cheating, mutualism, etc. have arisen [1].
These social strategies have been observed for both intra- and interspecies interactions [2,3].
Cooperation between organisms is established when goods produced by one organism
benefit other organisms in the population. The goods that are shared by multiple organisms
are termed the public goods. Cooperation can be mutualistic or unidirectional. Mutualism
is when all organisms contribute to the public goods and all organisms receive benefits from
the public goods. However, there is often a metabolic cost associated with production of
public goods [4]; thus, there is evolutionary pressure to consume the public goods without
contributing [5]. For a two species system, unidirectional cooperation is when one of the
species contributes to the public goods and the other does not. In unidirectional cooperation, the contributor is considered altruistic and the non-contributor is exploitive. The
exploitation can be parasitic [6–8] or benign [9].
Unidirectional cooperation can also occur intraspecifically when a fraction of the species
population stops contributing to the public goods [10, 11]. In this case, we consider the
contributors as cooperators and the non-contributors as defectors. For example, defectors
in the population of free living soil bacterium, M. xanthus, do not produce extracellular
lytic enzymes which kills and degrades the prey bacteria. They exhibit swarming behavior
and move with the contributors by pretending to participate in cooperative predation [12].
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The dynamics of how intercellular cooperation is developed, maintained, or gets terminated has remained a puzzling question. Adaptive evolution of the altruistic cells or
ecological changes can have an adverse effect on cooperation [4, 13]. This has been seen in
the cooperative strains of yeast down-regulating the expression of suc2 gene to prevent the
defectors from using the benefit of the secreted enzyme, invertase [13]. Likewise, changes in
ecological conditions may render the public goods fruitless in the new environment thereby
terminating the intercellular cooperation.
Game theory has been used to explore how different social strategies affect the evolution
of multicellular organism. The Prisoner’s dilemma [14] game has been used to frame a
variety of questions about the evolution and stability of cooperation. Two players needs
to cooperate in order to get average minimum penalty, however greed of individual benefit
triggers defection. The game shows that the cooperation is not chosen even when it is in
favor of the group. However when it is played recursively cooperation emerges between
the players [15]. Cooperation between organisms gives the best common fitness to the
population, however cheating gives higher individual fitness to the defector [16].
Microbes are increasingly used to investigate evolutionary questions [17–23]. One scenario of intraspecific exploitation of the common good is in the realm of antibiotic resistance [5, 24]. β-lactam antibiotics are commonly used to inhibit the growth of pathogens
like E. coli [25]. Ampicillin, a type of β-lactam antibiotic [26] can either be inactivated by
hydrolysis in the presence of β-lactamase or it would inhibit cell wall synthesis which is
simulated by sequestering the cellular materials required to produce biomass.
However a variant of E. coli contains a plasmid encoding for an antibiotic resistance
enzyme, β-lactamase [27]. β-lactamase catalyzes the hydrolysis of β-lactam antibiotics;
thereby, breaking the lactam ring and thus inactivating the antibiotic. Because the βlactamase is secreted it can inactivate antibiotic distal from the producing organism, thus
imparting protection on individuals that are not producing β-lactamase. Also, because
there is a metabolic cost associated with producing β-lactamase [28] there is an evolutionary
incentive for individuals to stop expressing the plasmid thus increasing their growth rate.
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However, if all of the individuals shed the plasmid then the population would be annihilated
by the antibiotic.
Yurtsev et al. [24] recently studied this phenomenon experimentally and developed a
phenomenological mathematical model to approximate the dynamics of the distribution of
individuals expressing the antibiotic resistance gene (R-strain) and individuals sensitive to
the antibiotic (S-strain). They found that resistant and sensitive cells of E. coli can co-exists
when subjected to antibiotic concentration lethal for the sensitive cells. The equilibrium
fraction of resistant cells in the population varies with β-lactamase efficiency and the antibiotics concentration. One of the shortcomings of Yurtsev et al.’s modeling approach is
that it failed to account for dynamic changes in growth rates of the R- and S-strain. In their
model, the R-strain always grows at a specified rate and the S-strain either doesnt grow or
grows at a specified rate if the antibiotic concentration drops below the minimum inhibitory
concentration. While phenomenological models, such as Yurtsev et al. and others [5], have
proven useful in studying the dynamics of cheating, these models do not provide insight
into the underlying influence of biochemistry on population dynamics.
COnstraint-Based Reconstruction and Analysis (COBRA) [29] is a molecular systems
biology modeling approach. COBRA employs genome-scale stoichiometric models of organisms to provide a systems level framework for investigating the connection between an
organisms molecular physiology and general phenotypes. COBRA has been most often used
in the realm of metabolism. Genome-scale models of metabolism (M-Models) aim to encapsulate all current biochemical reactions associated with an organisms metabolic processes
and relate them to the organisms genome. M-Models have been widely used in a variety
of application like detecting gene or metabolite essentiality [30], designing metabolic engineering strategies [31–33], investigating intercellular metabolic interactions [34], analyzing
evolutionary state of strains [35], etc. An attractive feature of the M-Models is that they
relate the genotype to the biochemical reactions and are amenable to insertion or deletion
of reactions as may occur during evolution.
Here we employ a multi-scale modeling approach (Figure 2.1a) to study the social
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dynamics between a plasmid-carrying antibiotic resistant strain (R-strain) of E. coli and an
isogenic mutant (S-strain) that has shed the plasmid.
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CHAPTER 2
METHOD
We employ a system of ordinary differential equations (ODEs) to simulate the population dynamics, and M-Models to estimate the growth rates of the strains (Figure 2.1a).
Microbial growth and population dynamics are simulated in a nutrient-limited medium (Table 2.1) in the presence or absence of antibiotics. We assume that our population is in log
phase growth in a chemostat-style reactor where unconsumed nutrients are washed out;
i.e., nutrients do not accumulate in the system. The maintenance and replication of the
antibiotic resistant plasmid and expression of its genes comes with a metabolic cost [36, 37]
which reduces the relative fitness of R-strains compared to S-strains in an antibiotic free
environment. In our simulations, we consider mutations which convert the slower growing
R-strains into the faster growing S-strains.
Table 2.1: Composition of the in-silico medium
Composition of
Ampicillin (antibiotics)
Ammonium (nutrients)

Inflow Rate
0 or 1
∼ 3.64 × 106

Scale
µg × ml−1 × hr−1
mmol × gDW−1 × hr−1

ODEs are used calculate the dynamics of the population density of the R and the S
strains [Equations 1 and 2]. Parameter values and sources are listed in Table2.2.
dR
= gR R − dR − pR
dt

(Equation1)

Equation 1 represents the growth dynamics of R as a function of time; it is comprised
of three parameters: gR , the specific growth rate for the R-strain; d, the natural death rate;
and, p, the probability of R mutating into S. gR varies as a function of population density
and is estimated using flux balance analysis (as described below) [38]. d is assumed to be
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1) Resistant cell’s growth rate gR
2) Sensitive cell’s growth rate gS

1) Antibiotic
2) Substrate

Metabolic Model
using Flux Balance
Analysis

Mixed Population
Dynamics using ODEs

1) Resistant cell’s count
2) Sensitive cell’s count
3) Unhydrolized antibiotic
count
1) Constraint on NH4 substrate uptake rate
2) Constraint on minimum antibiotic uptake
rate

(a)
Nutrients – refilled at the start of each cycle
Consumes

0.027 natural death

Consumes
Nutrients

Resistant
Strain

Sensitive
Strain
Grows at gR .

0.00514788
Mmol / (gDW x hr)

0.027 natural death

Grows at gS .

Mutation: 0.1% of population with the probability of 0.01

1
drained

β lactamase
1 mmol / (gDW x hr)
+

1485.3924 pg

β lactam
Antibiotic

2.088 pg

+

Sequested sensitive cell

1 µg/ml per hour
Hydrolyzed antibiotic

(b)

Figure 2.1: Multi-scale model to predict mix-population dynamics. (a): Based on the
current fitness of the strains, the ODEs are used to calculate the change in the ecological
conditions and population structure. Based upon the changes in the ecological conditions
represented in the extracellular reaction of the M-Model, the new fitness of various strains
is estimated. This process is repeated in recursion. (b): A schematic view of framework
to simulate mixed population dynamics of resistant and sensitive cells in an antibiotic
medium. The R-strains produces β-lactamase which helps in improving the overall fitness
of the population.
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constant and is estimated at 2.7% [39]. p is assumed constant for a simulation and we
explore a range of mutation probabilities.
dS
= gs S − dS + pR
dt

(Equation2)

Equation 2 represents the growth dynamics of S as a function of time; it is comprised
of three parameters: gs , the specific growth rate for the S-strain; d, the natural death
rate; and, p, the probability of R mutating into S. gs varies as a function of population
density and is estimated using flux balance analysis (as described below). d is assumed to
be constant and is estimated at 2.7% [39]. p is assumed constant for a simulation and we
explore a range of mutation probabilities.
dA
= i − hRA − cSA
dt

(Equation3)

In each iteration, R-strains can produce β-lactamase which in-turn inactivates βlactam. We assume that the un-hydrolyzed antibiotic can divert cellular material away
from the biomass reaction of the S-strain, thus inhibiting its growth-rate (Figure 2.1b).
Equation 3 represents the antibiotic concentration as a function of time; it comprise of
three terms: i, the feed rate for the antibiotic; hRA, hydrolysis of antibiotic by the R strain
where h is the hydrolysis coefficient; and, cSA, antibiotic sequestered by the S strain.
FBA with linear optimization is a method that is commonly used to estimate maximal
yields of biomass or byproducts from a set of substrates by a metabolic network. Here,
we use FBA with our M-Models to estimate the growth rates of the R- and S-strains as a
function of nutrient availability and antibiotic concentration.
We use the results of the ODE simulations to set the boundary conditions for the MModels of the R and S strains (described in detail below) and then use linear programming
via the COBRApy package [40] to identify the maximal growth rates achievable for the
strains. We assume that ammonium, NH4 , is the limiting nutrient and that nutrient availability is directly proportional to the frequency of the strains; e.g., the flux of NH4 available
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to the R strain is NH4 x R / (R + S), where NH4 is the in silico flux of NH4 into the system
(Table 2.1), and R and S are calculated from Equations 1-2. Because the growth rates vary
nonlinearly as a function of time, we simulate this system in an iterative fashion with a one
hour time step.
Table 2.2: ODE parameter description, units, and values
Legend
R
S
A
gR
gs
h
i
c
p
d

2.1

Specification
Density of Resistant Bacteria
Density of Sensitive Bacteria
Antibiotic concentration
division rate of R bacteria
division rate of S bacteria
rate of hydrolysis of antibiotic
antibiotic feed rate
rate of consumption of antibiotic
probability of mutation event
natural death rate of bacteria

Value

from FBA
from FBA
2.088 × 10−6
1
2.088 × 10−6
0.00001
0.027

Scale
cell × ml−1
cell × ml−1
µg × ml−1
cell−1 × hour−1
cell−1 × hour−1
µg × cell−1 × hour−1 × ml−1
µg × ml−1
−1
µg × cell × hour−1 × ml−1
cell−1 × hour−1

M-Model extension
Figure 2.2 represents the extension applied to existing M-model of E. coli to study the

metabolic activities inside the bacteria in antibiotic-containing environment. The R-strains
get preferential access to the benefits of β-lactamase by keeping the β-lactamase produced
in its periplasmic region before the excess amount is secreted into the medium [41]. To
avoid the complexity of spatial distribution of β-lactamase we assume that β-lactamase
is not secreted and we increase the hydrolysis rate of ampicillin per cell to account for
extracellular hydrolysis of ampicillin. As a result, the fitness of an R-strain is independent
of the frequency of R-strains.
To simulate antibiotic exposure, we add ampicillin to the in silico medium containing
the bacteria by creating a system boundary reaction. Extracellular antibiotic is free to
diffuse into the periplasmic compartment of the cell where it may be hydrolyzed by βlactamase (Figure 2.2a). If no β-lactamase is present in the periplasmic compartment, the
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antibiotic diffuses into the cytoplasm where it reacts with the biomass precursor metabolites
(Figure 2.2b) thus effectively reducing the amount of biomass produced from the nutrient
medium.

2.2

Description of the reactions added in the M-Model of E. coli

2.2.1

Production of Beta-lactamase

We constructed a mass balanced equation for the production of β-lactamase from precursors (Figure 2.3) based on the E. coli K12 sequence of β-lactamase from Uniprot [42].
Energy in the form of ATP is required for forming peptide bonds during protein expression. Approximately 4.3 molecules of ATP into ADP per molecule of amino acid [43]. Since
there are total of 286 molecules of amino acids in β-lactamase, we need 1229.8 molecules
of ATP. Because the set of metabolites required for the production of β-lactamase is a
subset of the biomass precursors, expression of β-lactamase will reduce the fraction of substrate that may be converted into biomass. In our system, we assume that β-lacatamase is
constitutively expressed at a constant level.
Yurtsev et al. [24] experimentally observed that at 37o C in 5ml of LB and 5g/ml of
Kanamycin that gR v gs 0.87 . Here, we assume that the decrease in growth rate is entirely
due to expression of β-lacatamase. To calculate how much β-lacatamase is being expressed,
we first simulate the optimal gs subject to the medium composition. Next, we simulate the
maximal β-lacatamase production rate subject to the medium composition and a growth
rate of gs 0.87 . With these calculations we determine that the maximal moles of β-lacatamase
generated per hour per gram dry weight of E. coli is approximately 0.00515. For further
simulations, we set R cells to produce β-lacatamase at 0.00515 moles / gDW / hr unless
otherwise stated.

2.2.2

Hydrolysis of ampicillin

To estimate the hydrolysis efficiency of β-lactamase, we consider empirical data from
Yurtsev et al. [24]. At steady state the amount of enzyme produced equals the amount of
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a.

Resistant Strain

β-lactamase_p

β -lactamase
β-lactamase_c
Precursors β-lactamase

β-lac
tama

se_t
pp

ADP, pi, H+

β-lactam Hydrolysis

H20_p

Production

β
E x_

β-lactam_p

Cytoplasm

-L a

m
cta

β-lactam_e

β - L ac
tam_
tex

Periplasm
Extra-cellular

b.

Sensitive Strain

β-lactam_c
β- L

β-lactam_p

Ex_β-Lactam

am
act

act
am
_tp
p

β-L

Biomass
Precursors

x
_te

Cytoplasm

β-lactam_e

Sequestering of Biomass
Periplasm

Extra-cellular

Figure 2.2: Block diagram of extended model of Escherichia coli. Depending on the active
pathways different phenotype is exhibited by the strain. a) The compartmental view of Rstrain, β-lactamase present in the cytoplasm is secreted into the periplasmic compartment
which would react with the β-lactam antibiotic (if penetrated or present in the medium)
termed as a β-lactam hydrolysis. b) The absence of β-lactamase production denotes a
sensitive strain which cannot defend itself from damages caused by β-lactam antibiotic. βlactam antibiotics sequester the nutrients employed to build a sensitive strain by diverting
essential cellular material to the sink.
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pi
b-lactamase
precursors

h

bLactamase Production

adp

atp
bLactamase

Figure 2.3: β-lactamase Production: 14 proline + 15 valine + 11 lysine + 4 tyrosine + 20
threonine + 8 asparagine + 29 alanine + 9 glutamine + 4 tryptophane + 20 glutamate +
16 aspartate+ 3 cysteine + 10 methionine + 7 histidine + 10 phenylalanine + 17 isoleucine
+ 16 serine + 19 arginine + 21 glycine + 33 leucine + 1229.8 atp + 1229.8 h2o −→ 1229.8
h +1229.8 adp + 1229.8 phosphate + 1 bLactamase
enzyme degraded and diluted. We use Yurtsev et al.’s [24] adjusted (increased to incorporate
extracellular hydrolysis) maximum rate of hydrolysis, 106 molecules / (cell x seconds)
106 molecules
seconds
grams 1012 picograms
1mole
× 3600
× 349
×
×
cell × second
hour
mole
gram
6.022 × 1023 molecules
picograms
= 2.088
cell × hours
=

Since 2.088 pg / cell / hr of ampicillin is hydrolyzed by 0.00515 moles of β-lactamase /
gDW / hr / cell, 1 β-lactamase can hydrolyze 405.437 picograms of ampicillin (Figure 2.4).
We assume that this rate of 2.088 pg / cell / hr represents the upper limit on ampicillin
diffusion into the cell.

2.2.3

Sequestion of biomass

Based on our calculation above, we assume that 2.088 pg / hr of ampicillin can diffuse
into an S cell and sequester biomass. We further assume that 2.088 pg of ampicillin can
sequester 1 cell per hour. We represent this sequestration by a biomass degradation sink
reaction (Figure 2.5) that diverts biomass precursors away from biomass thus inhibiting the
cellular growth rate.
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Figure 2.4: Hydrolysis of β-Lactam: 1bLactamase + 405.437h2o + 405.437ampicillin −→
405.437hydrolized ampicillin

biomass
precursors

Biomass Degradation

Ampicillin

Figure 2.5: Ampicillin reacts with precursors of biomass to inhibit the division of the
bacteria. Precursors of biomass + 2.088ampicillin −→ (leaves the system)
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CHAPTER 3
RESULTS AND DISCUSSION
Using the ODEs, we model the growth of R and S strains in nutrient-limited medium
with various conditions. The substrate we are limiting is ammonium (NH4 ). Wang et al.
have observed an approximate natural death rate of E. coli is 2.7% per generation [39]. At
optimal growth rate we observe the doubling time of our strain to be approximately one
hour, therefore both strains are subjected to a natural death rate of 2.7% per hour.

3.1

Growth in antibiotic-free medium
To investigate the impact of constitutively expressing β-lactamase (R-strain) versus not

expressing (S-strain), we simulate growth in antibiotic free medium. With a limiting supply
of ∼ 3.64 × 106 mmol / gDW / hr NH4 , the S-strain can realize a population density of
1.2 × 107 cells/mL when grown in isolation(Figure 3.1a). Whereas, the R-strain can realize
a saturation density of 1.58 × 106 cells/mL (Figure 3.1a). Hence, our model recapitulates
the reduced fitness of R vs S strain due to constitutively expressing β-lactamase.
When we start with a mixed population of R- and S-strain (initial densities of 1 × 105
cells / mL for both strains), we observe that over time the S-strain completely dominates the
population (Figure 3.1b). Dominance of the population by the S-strain is expected because
there is a non-zero cost, c, associated with producing β-lactamase and a zero benefit, b.
Because the R-strain pays c without receiving any b, wed expect it to be less fit than the
S-strain which does not pay any c and does not receive any b.

3.2

Growth in the presence of ampicillin
To investigate how a non-zero b associated with β-lactamase production influences the

population dynamics, we simulated the dynamics of a mixed population in the presence
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Figure 3.1: The dynamics of R- and S- cells in antibiotic free NH4 limited medium. a) Both
cells are independently grown to saturation. Saturation density of the sensitive cells is 1.2
× 107 cells/ml. The metabolic burden incurred in constitutively expressing β-lactamase
reduces the saturation density of resistant cells to 1.58 × 106 cells/ml. b) Cells are grown
together. More fit sensitive strains completely dominate the population by driving the less
fit resistant cells to extinction.
of ampicillin (Figure 3.2). The initial composition was 103 cells each of the R-strain and
S-strain. Ampicillin was fed to the medium at a rate of 1 µg/(hour × mL). And, NH4 was
the limiting nutrient with a feed rate of ∼ 3.64 × 106 mmol / gDW / hr.
At low frequencies of R-strains, the S-strains are unable to survive but the R-strain
continues to flourish (Figure 3.2a t=0 to 18) which implies that the benefit of the public
good is not uniformly available. This is because the R-strain gets preferential access to the
scarce β-lactamase (in their periplasm) which becomes critical for their survival. Hence at
the lower frequency of the cooperators (R-strain), the relative fitness of the cooperators is
higher than the defectors (S-strain) (Figure 3.2b). The advantage of initial access of public
goods to its producer has been observed experimentally in budding yeast [44, 45].
As the frequency of cooperators increases, they inactivate more antibiotic per unit
time resulting in the drop of un-hydrolyzed antibiotic concentration below the minimum
inhibitory concentration (MIC) thus making the environment conducive for the simultane-
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ous growth of both strains. As the frequency of the R-strain increases above ∼ 1.36 × 106
cells/mL, the S-strain is able to freeload on the excess β-lactamase activity expressed by
the R-strain (Figure 3.2a, t=19 to 70). Detoxification of the medium by the R-strain leads
to an increase in the S-strains fitness (i.e., net growth rate) versus the R-strains fitness from
19 hours until equilibrium is achieved (Figure 3.2b).
The invasion of the S-strain into the population stimulates the relative decline of the
R-strain which compromises the ability of the population to inactivate ampicillin, thus
decreasing in the fitness of the defectors. As cheating is facultative, it sets up an evolutionary
feedback loop through which the population is driven to an equilibrium frequency of the
strain (Figure 3.2c). Our simulation results of an evolutionary feedback loop leading to
a stable cooperation, are consistent with the observations made by previous researchers
[44, 46–48].

3.3

Growth with mutation in ampicillin-containing medium
In our previous simulations, we either grew the two strains in isolation or directly

competed them against each other. Because there is a metabolic burden associated with
constitutively expressing β-lactamase (Figure 3.1a), there is evolutionary incentive for members of the R-strain population to stop expressing β-lactamase to increase their growth rate.
To model the evolutionary pressure to defect, we include a non-zero probability of mutation
for a portion of the R-strain population into the S-strain variant. The probability of a
mutation is 0.001 / hr and in each such mutation event we allow random 0.01 R-strains
to convert into S-strains; therefore giving the net probability of mutation from R −→ S as
0.00001 per hour. After performing the simulations, we notice that versus no mutation (Figure 3.2b) the equilibrium fraction is identical (Figure 3.3a).Since the equilibrium frequency
of the strains is driven by relative strengths of the strains which in turn depend on current
antibiotic inflow rate, maximal amount of nutrients, cost to produce the public good, and
the benefit derived from the public good, our model accurately predicts no change in the
equilibrium frequency due to the introduction of mutation.
While the opportunity to mutate from R into S does not change the equilibrium point,
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Figure 3.2: Evolution of cooperation between resistant and sensitive cells. Since the ability
of the S-cell to cheat is conditional on the frequency of R-strain, the cooperation is stable.
a, b) The relative strength of S-cells is lower than R-cells at low frequency of R-strain.
However at higher frequencies of R-strain, the relative strength of S-cells is higher and they
invade the population. c) The invasivibility of sensitive cells is controlled by the minimum
required amount of public goods setting up and evolutionary feedback loop driving the
population towards equilibrium. d) The growth-rate of the two strains also oscillates and
once the population reaches zero, the new growth rate remains at zero.
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it decreases the amount of time required by the sensitive strain to invade into the population
when the cooperation is being established. During the initial growth of sensitive cells, their
population reaches to a peak value from where it is driven to an equilibrium frequency. In
Figures 3.3b, 3.3c, and 3.3d, we show that the time for the sensitive cells to reach their peak
(and thus equilibrium) decreases as a function of increasing mutation rate. Interestingly,
when the mutation rate increases beyond a certain value (here 0.0003 for default antibiotic
and β-lactamase efficiency) the system does not reach an equilibrium point; instead it
continuously oscillates. As the mutation rate increases to 100% the population is driven to
extinction because all R-strains are mutated into S-strains and no ampicillin is detoxified
(data not shown).

3.4

Influence of cost to benefit ratio of the public good
Fitness of the population is dependent on the cost to benefit ratio of the public good.

If the benefit increases and the cost decreases then the cooperators fitness should increase.
In our system, we can modulate the cost to benefit ratio by varying the efficiency of the
catalytic activity of β-lactamase and by varying the β-lactam antibiotic efficiency (Figure
3.4a). In our simulations there are four distinct regions: (1) the S-dominated region; (2) the
R-dominated region; (3) the non-equilibrium region, where the system continually oscillates;
and (4) the mixed region.
The S-dominated region signifies the end of cooperation between R- and S-cells which
initially existed (Figure 3.4b). The cooperation allows the population of S-cells to grow to
its peak as noted earlier. However, due to low antibiotic efficiency and the distribution of
damage within S-cells, the average effective damage on the S-cells is less than the cost of
producing β-lactamase i.e. cost to benefit ratio goes above one. Thus the relative fitness of
S-cells remains higher than the R-cells driving the R-cells to extinction. Hence we see a new
form of cooperation being evolved among the S-cells and termination of their cooperation
with the R-cells.
The R-dominated region indicates that the cooperation between the R- and the S-cells
could not be established (Figure 3.4c). Due to low β-lactamase efficiency, β-lactamase is
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Figure 3.3: The ability to defect allows some resistant cells to convert into sensitive cells. a)
Using net probability of mutation as 0.00001, it can be seen that the equilibrium distribution
of the population does not depend whether or not mutation occurs. b,c,d) The time taken
by the sensitive cells to reach their peak population decreases due to mutation.
completely utilized by the R-cells through their preferential access. Thus the defector S-cells
do not get an opportunity to exploit the benefits of β-lactamase and fail to sustain. Based
on these results, reduction of β-lactamase efficiency looks to be an interesting evolutionary
state for the R-strain to protect itself of exploitation from the S-strain.
If the β-lactam efficiency is increased such that 1.888pg of antibiotic can completely
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inhibit cell division, the evolutionary feedback loop fails to dampen the oscillation and
equilibrium cannot be predicted.
If the cooperation between the R- and S-cells could be evolved and enters a stable state,
both strains co-exists. Our model estimates the equilibrium frequency of the two strains
is based on the relative strengths of the strain in the given environment. The fraction
of R-cells at equilibrium increases with decrease in β-lactamase efficiency and increase in
β-lactam efficiency.

3.5

Evolutionary analysis of anti-cheating strategies
Adaptive evolution has been shown to “tune” microbes to their environments [49, 50].

For example, when E. coli was subjected to adaptive evolution through serial passaging,
they improve their growth rate by more efficiently converting the substrate into biomass
(yield) [35]. Two common methods for adapting to an environment are: (1) altering enzyme
efficacy and (2) modulating enzyme expression. Here, we expand our simulations to allow
the R strain to mutate into variants that have increased, or decreased, enzyme efficiencies
or enzyme expression ratios. Then, we “compete” all of the strategies together to determine
which alternatives might fix themselves in the population when cheating is allowed (Figure
3.5).
The dynamics show that with varying β-lactamase expression levels, the 0.5R-strains
tend to be relatively more fit (Figure 3.5) than other strains expressing β-lactamase. Since
variants of R-strains have no interdependence on each other, population of 1R-strain and 2Rstrain are expected to reach extinction through dominance of the more fit 0.5R strain [51].
Mutations that result in higher relative fitness of R-strains are expected during evolution. If the cell has control over its plasmid count, our results show that the cell would
maintain a lesser number of these plasmids. Our model predicts that for the given antibiotic
inflow rate and minimal substrates, if the cell reduces the β-lactamase production to 0.275
mmoles / cell / gDW / hr, the entire population would be dominated by the resistants and
the cooperation between R and S strain would not evolve.
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Figure 3.4: Effect of change in β-lactam and β-lactamase efficiency on the equilibrium
distribution of the two type of cells. a) The fraction of resistant cells at equilibrium increases
with increase of antibiotic efficiency and decrease of β-lactamase efficiency. b) Cooperation
evolved between R- and S-cells at low β-lactam efficiency eventually gets terminated as
the cost to benefit ratio of β-lactamase increases above one. c) Low β-lactamase efficiency
increases its consumption from its producer through preferential access. As a result, benefits
of β-lactamase are not freely available to the S-cells.
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Figure 3.5: Comparison of alternative strategies to improve the strength of R-strain. Altering the amount of β-lactamase expressed can result in better improvement in the fitness of
the evolved strain compared to altering the efficiency of the β-lactamase expressed. (a) In
the presence of the defectors, evolved strain down regulating the β-lactamase expression is
more fit than its ancestral strain. However, this evolution could reduce the resilience of the
population. No cooperation is established between other evolved strains of resistants and
only the fittest strain survives. (b) By altering the catalytic activity of β-lactamase, the
metabolic burden of reducing β-lactamase is not reduced. With the same metabolic burden
the evolved strain exhibit similar fitness as ancestral strains. Because we allow mutations
from ancestral strain to evolved strain, a steady decline of ancestral strain is observed.
3.6

Utilization of cellular materials
While we use the M-models to estimate the growth rate of the strains, they additionally

provide valuable information about the expression of genes functions required to convert
growth substrate into biomass. Let us consider the total number of ATP molecules employed
in (i) generation of β-lactamase and (ii) sequestered due to lack of β-lactamase. The utility
of ATP molecules for the population could be constituted as the fraction of ATP molecules
utilized in producing β-lactamase. Figure 3.6 shows that the utility of ATP decreases as
the β-lactam efficiency decreases and β-lactamase efficiency increases.
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Figure 3.6: Analysis of utilization of cellular materials. The utility of ATP decreases as the
β-lactam efficiency decreases and β-lactamase efficiency increases
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CHAPTER 4
CALCULATION OF EQUILIBRIUM
Let us consider there are r resistant cells and s sensitive cells at equilibrium. Since the
population remains constant at equilibrium, the division rate of the cells nearly equals the
natural death rate of the cells. Because the division rate of resistant cells is controlled only
by the substrate availability, using linear programming we identified that the minimum NH4
uptake required to support constant resistant population is 2.30224 mmol/(gDW x hour x
cell). In this experiment, all cells are subjected to the same NH4 uptake rate and total NH4
available for entire population is approximately 3.64 x 106 mmol/(gDW x hour x cell) we
get:
2.30224r + 2.30224s ≈ 3.64 × 106
Therefore,

r

+

s

≈ 1.58 × 106

(Equation 4)

Normally, sensitive cells grow faster than resistant cells. However, when subjected
to antibiotics, division rate of sensitive cells is reduced. At equilibrium the division rate
of sensitive cell also equals its natural death rate. Since the natural death rate of both
the cells is same, the division rate of sensitive cell equals division rate of resistant cell
for the same NH4 uptake rates. Again using linear programming, we identified that the
amount of antibiotic required per sensitive cell to support the growth rate and NH4 uptake
rate identical to resistant cells to be 0.38713pg. Each resistant cell hydrolyzes 2.088pg of
antibiotic per hour. Total of 1µg of antibiotic enters per ml of the system. Therefore, we
can conclude:
2.088r + 0.38713s = 1 × 106

(Equation 5)

Solving equations 4 and 5 simultaneously, we get at equilibrium:
r ≈ 2.28 × 105 ≈ 105.36
s ≈ 1.58 × 106 ≈ 106.20
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Results shown in Figure 3.2b matches with the mathematical calculations. It should
be noted that the population distribution at equilibrium does not depend on the population
distribution at the start of the simulation or the probability of mutation. Hence, the
equilibrium state of mixed population of E. coli remains same irrespective of the initial
population distribution or the probability of mutation (with an exception that at least a
single resistant cell should be present during kickoff).
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CHAPTER 5
CONCLUSIONS AND FUTURE WORK
We extended the M-Model of E. coli to accommodate the production of β-lactamase,
hydrolysation of ampicillin and sequestering the nutrients. Our M-model incorporates the
metabolic burden of producing β-lactamase. Having different pathways active in R and S
strains, the model exhibits the difference in the observed phenotype of these two isogenic
strains.
Using M-model we simulate the fitness of the strains proportional to the prevalent
ecological condition including the antibiotic concentration. These simulations are consistent
with the in-vitro observation that antibiotics affect the fitness of the sensitive pathogens
even at concentrations below MIC [52]. Such mechanistic estimation is not possible in
previously developed phenological models.
Our multi-scale modeling approach of ODEs and M-Models simulates the population
dynamics. It predicts the equilibrium state of the mixed-population in a given condition
(from all cooperator, all defectors, or a stable coexistence of defectors and cooperators)
that depends on the relative strengths of the strains involved. Using bacterial antibiotic
resistance as a guide, the model gives insights into the dynamics of cooperation (evolution,
maintenance and termination) between the altruistic contributors and the exploitive defectors. The impact of cooperators getting preferential access to β-lactamase has many fold
impact on the stability of cooperation. It limits the cheating ability of the defectors during
scanty supply of public goods which allows the cooperators to grow. In addition, we show
how a portion of the antibiotics is left unhydrolysed at equilibrium, which results in reduction of the relative benefit of public good on free loading defectors. This brings down the
strength of the defectors in-line with the cooperators to maintain stable cooperation. Using
our approach, we modify the benefit value of β-lactamase and show that at low β-lactam
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efficiency the cooperation between R- and S-cell eventually terminates. Similarly, at low
β-lactamase efficiency the cooperation between the two cell-types fails to evolve.
Through this model, it is possible to draw various cellular level insights across various stages of cooperation. The utility of ATP molecules increases as the number of ATP
molecules sequested in ampicillin inhibited cell decreases. Although increased antibiotic
efficiency and decreased β-lactamase efficiency reduces the fitness of the sensitive cells, our
results show it leads to an increased utility of ATP molecules at equilibrium.
Organisms may employ various strategies to improve their fitness in the given conditions. Through this work it is possible to compare the efficacy of such strategies. We show
that for cooperating strains of E. coli, regulation of β-lactamase expression is superior to
modulation of its catalytic activity. In addition, we quantitatively measure the feasible
scope of gene regulation. It shows that the resistant strain of E. coli could express 0.275
mmoles / cell / gDW / hr to completely dominate the population.
Though we use two species cooperator-cheater paradigm, our approach can be utilized
to study other complex types of cooperations having multiple species. Based on the phenotypic activity of each specie, the ecology of the population can be approximated in the
M-model. This consequently estimates the traits of each strain in the following iteration.
Our work drives a hypothesis for new experiment to verify the evolutionary state of E. coli
in terms of β-lactamase expression and the corresponding plasmid count.
Insights from microbes elucidates key evolutionary states in multicellular organisms.
Using a strains representing each cell-type in multicellular organism, characteristic features
driving the co-existence of differentially fit cells can be drawn.
In our work we allow specific predefined types of mutation. The work can be extended
to accommodate new strains generated through random in-silico mutation. These models
can then predict genetic perturbations required to reach a particular evolutionary state. For
example, cancer is caused due to generation of a mutant with a higher relative fitness and
not requiring cooperation from many essential cells. Thus they invade the medium causing
extinction of essential cells required for default functioning of an organism [53–55].
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[51] M. K. Applebee, M. J. Herrgå rd, and B. O. Palsson, “Impact of individual mutations on increased fitness in adaptively evolved strains of Escherichia coli,” Journal of
Bacteriology, vol. 190, no. 14, pp. 5087–5094, 2008.
[52] L. J. Drummond, D. G. E. Smith, and I. R. Poxton, “Effects of sub-MIC concentrations
of antibiotics on growth of and toxin production by Clostridium difficile,” Journal of
Medical Microbiology, vol. 52, no. 12, pp. 1033–1038, 2003.
[53] L. M. F. Merlo, J. W. Pepper, B. J. Reid, and C. C. Maley, “Cancer as an evolutionary
and ecological process,” Nature Reviews Cancer, vol. 6, no. 12, pp. 924–935, 2006.
[54] B. Austin, R. Trivers, and A. Burt, Genes in conflict: the biology of selfish genetic
elements.

Harvard University Press, 2009.

[55] M. Greaves and C. C. Maley, “Clonal evolution in cancer,” Nature, vol. 481, no. 7381,
pp. 306–313, 2012.

